Eli Lilly and Company (LLY): The Best Dividend Growth Stock With Over 10% Yearly Increases?
We recently compiled a list of the 13 Best Dividend Growth Stocks With 10%+ Yearly Increases. In this article, we are going ...
Biogen (BIIB) Receives a Buy from Evercore ISI
In a report released on February 7, Umer Raffat from Evercore ISI maintained a Buy rating on Biogen (BIIB – Research Report). The company’s ...
Korea JoongAng Daily on MSN13h
Olix, Eli Lilly to develop liver disease drug under $630 million deal
Olix Pharmaceuticals signed a $630 million licensing deal with Eli Lilly to develop treatments for cardiovascular and ...
24/7 Wall St.6h
My 3 Top Picks for Stocks That Could Double Over the Next 3 Years
Finding stocks with the potential to double in just three years is no easy feat, even in this bull market. Plenty of ...
pharmaphorum20h
Novo joins Lilly in asking FDA for ban on GLP-1 compounding
The request follows a similar move by Eli Lilly, which has asked for a ban on ... that it accuses of unlawfully making semaglutide. The company has claimed that compounded semaglutide with ...
Eli Lilly enters global license agreement with OliX for OLX75016
OliX Pharmaceuticals announced a global licensing agreement with Eli Lilly (LLY). This collaboration focuses on the development and ...